Henderson Michael Thomas's Form 4 filing
Apogee Therapeutics, Inc. (APGE) · filed Jun 12, 2026
- Accession no.
- 0001104659-26-073567
- Filed
- Jun 12, 2026
- Trade date
- Jun 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.67M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Michael ThomasCIK 0001779990 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | SSaleDisposed | −6,770 | $82.21 | −$556,561.7 | 1,109,217 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −7,654 | $82.78 | −$633,598.12 | 1,101,563 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −1,080 | $84.18 | −$90,914.4 | 1,100,483 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −1,577 | $85.19 | −$134,344.63 | 1,098,906 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −2,305 | $86.27 | −$198,852.35 | 1,096,601 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −614 | $86.89 | −$53,350.46 | 1,095,987 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.